Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Therapix Biosciences (TRPX)

Therapix Biosciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRPX
DateTimeSourceHeadlineSymbolCompany
26/06/202321:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/06/202314:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/06/202314:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
12/06/202312:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/05/202321:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/05/202311:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/05/202322:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TRPXTherapix Biosciences Ltd
08/05/202313:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/05/202321:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/04/202314:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/04/202311:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
04/04/202312:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
10/03/202322:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
09/03/202321:16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202314:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202312:47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/02/202311:01Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:TRPXTherapix Biosciences Ltd
16/02/202322:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
15/02/202313:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/01/202321:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
09/01/202321:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
14/12/202221:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
07/12/202218:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
29/11/202217:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/11/202221:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
08/11/202212:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
01/11/202220:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/09/202212:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/09/202216:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/08/202211:56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TRPX

Your Recent History

Delayed Upgrade Clock